Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN101497639B details a scalable Decitabine synthesis using toluoyl protection and fractional crystallization, offering significant cost reduction in pharmaceutical manufacturing.
Novel 6-step synthesis for GalNAc analogues offers high purity and scalable production. Ideal for siRNA conjugates and liver targeting delivery systems.
Patent CN111925335B reveals a base-catalyzed route for 5-amino-1,2,3-triazoles, eliminating expensive metals and toxic azides for safer, scalable pharmaceutical manufacturing.
Advanced Pd-catalyzed route for Palbociclib Intermediate II. High yield, cost-effective process for API manufacturing.
Patent CN102766004B reveals a one-step copper-catalyzed method for aminoacyl arylamine synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN103665064B details a novel three-step synthesis for high-purity sugar intermediates, offering significant cost reduction and scalable manufacturing solutions.
Patent CN113388852B reveals a green electrochemical method for pyrido purine synthesis, offering high purity and cost reduction for pharmaceutical intermediate manufacturing.
Patent CN103664911B reveals metal catalytic coupling for Vilazodone intermediates ensuring high purity and scalable supply chain reliability for global pharmaceutical manufacturers.
Novel palladium-catalyzed decarboxylative [5+3] cycloaddition patent offers high enantioselectivity and mild conditions for scalable pharmaceutical intermediates manufacturing supply chain.
Patent CN113461743A reveals a cost-effective 4-step route for crosslinkable nucleosides, eliminating chromatography and enabling high-purity oligonucleotide manufacturing.
Novel phosphonylation method for fosaprepitant dimeglumine intermediate. Enhances yield, purity, and supply chain reliability for global pharmaceutical manufacturing partners.
Advanced preparation of c-Met inhibitor intermediates via Pd-catalyzed coupling. Enhances purity and supply chain reliability for pharmaceutical manufacturing.
Patent CN115304465B reveals green carbonyl synthesis. Reduces toxic waste and enhances supply chain reliability for global pharmaceutical intermediates manufacturing.
Patent CN106632086B details a Rhodium-catalyzed C-H iodination method for quinazolines. This process offers high purity, mild conditions, and significant cost reduction in pharmaceutical intermediate manufacturing.
Novel patent CN103087121B offers high-purity IPTG synthesis without toxic mercaptans, ensuring cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN104447515A reveals a novel Ceritinib intermediate route avoiding expensive Platinum Dioxide. Discover cost reduction and high-purity supply chain solutions.
Discover the novel Wittig-based synthesis of Rosuvastatin intermediates via Patent CN1307187C. Achieve higher yields and safer processing for statin manufacturing.
Patent CN101084197B discloses a novel Heck coupling process for Rosuvastatin intermediates, offering improved scalability and cost reduction in pharmaceutical manufacturing.
Patent CN102533888B enables continuous enzymatic production of high-purity L-tert-leucine. Reduces costs and ensures supply chain reliability for API manufacturing.
Patent CN104178548A details high-purity S-2-naphthylethylamine synthesis via lipase. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.